How does the IMF help accelerate new drug approvals? (https://www.myeloma.org/videos/how-does-imf-help-accelerate-new-drug-approvals)
In this week's video, Dr. Brian G.M. Durie answers the question on how the International Myeloma Foundation contributes to the acceleration of new drug approvals for multiple myeloma.
Bottom Line:
The IMF's work helps expedite the progress of new drugs from trial phase to full approval.
Ask a Question
Please note that Ask Dr. Durie has been discontinued, and it was designed to address myeloma questions of the broadest possible audience interest. If you have a question of a personal nature, please contact our InfoLine Coordinators at 800.452.2873 or [email protected] (mailto:[email protected]) (Please do not send email attachments or lab reports.).
Dr. Brian G.M. Durie (1942-2025) was the co-founder of the IMF. He was a Professor of Medicine, Hematologist/Oncologist, and Honoree MD at the University of Brussels.